{"id":2993,"date":"2011-02-21T08:38:27","date_gmt":"2011-02-21T15:38:27","guid":{"rendered":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/?p=2993"},"modified":"2011-02-21T08:38:27","modified_gmt":"2011-02-21T15:38:27","slug":"dwarfism-mutation-may-protect-from-cancer-diabetes","status":"publish","type":"post","link":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/?p=2993","title":{"rendered":"Dwarfism Mutation May Protect From Cancer, Diabetes"},"content":{"rendered":"<p>Genetic variant that stunts growth may have health benefits, researchers suggest<\/p>\n<p>By Robert Preidt<br \/>\nWednesday, February 16, 2011<br \/>\nWEDNESDAY, Feb. 16 (HealthDay News) &#8212; A genetic mutation that causes a type of dwarfism may also protect against cancer and diabetes, a new study finds.<\/p>\n<p>The finding suggests it may be possible to use drugs or other methods to achieve similar protection in normal-height adults, said study authors Valter Longo, a University of Southern California cell biologist, and Ecuadorian endocrinologist Jaime Guevara-Aguirre.<\/p>\n<p>Their research included people in a remote community on the slopes of the Andes mountains. Many members of the community have Laron syndrome, a deficiency in a gene that prevents that body from using growth hormone.<br \/>\n<!--more--><br \/>\nFor 22 years, the researchers followed about 100 people with Laron syndrome and 1,600 of their normal-stature relatives. During that time, no one with Laron syndrome developed diabetes and only one person got cancer, while 5 percent of their relatives were diagnosed with diabetes and 17 percent with cancer.<\/p>\n<p>The study appears in the Feb. 17 issue of Science Translational Medicine.<\/p>\n<p>&#8220;The growth hormone receptor-deficient people don&#8217;t get two of the major diseases of aging. They also have a very low incidence of stroke, but the number of deaths from stroke was too small to determine whether it&#8217;s significant,&#8221; Longo said in a university news release.<\/p>\n<p>There are already drugs approved by the U.S. Food and Drug Administration that block growth hormone activity. Currently, those drugs are used to treat acromegaly, a condition related to gigantism.<\/p>\n<p>Other research has found that caloric restriction and fasting also reduce growth hormone activity, according to the news release, although going without food and nutrients carries risks.<\/p>\n<p>Overall lifespan was the same for both groups, but those with Laron syndrome died more often from substance abuse and accidents.<\/p>\n<p>&#8220;Although all the growth hormone deficient subjects we met appear to be relatively happy and normal and are known to have normal cognitive function, there are a lot of strange causes of death, including many that are alcohol-related,&#8221; Longo said.<\/p>\n<p>SOURCES: University of Southern California, news release, Feb. 16, 2011<br \/>\nHealthDay<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genetic variant that stunts growth may have health benefits, researchers suggest By Robert Preidt Wednesday, February 16, 2011 WEDNESDAY, Feb. 16 (HealthDay News) &#8212; A genetic mutation that causes a type of dwarfism may also protect against cancer and diabetes, a new study finds. The finding suggests it may be possible to use drugs or [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[103],"tags":[],"_links":{"self":[{"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=\/wp\/v2\/posts\/2993"}],"collection":[{"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2993"}],"version-history":[{"count":4,"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=\/wp\/v2\/posts\/2993\/revisions"}],"predecessor-version":[{"id":2997,"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=\/wp\/v2\/posts\/2993\/revisions\/2997"}],"wp:attachment":[{"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2993"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.mlgsca.mlanet.org\/newsletter\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}